Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53
Clinical trial NCT03975387 · TERMINATED
Trial details
- NCT number
- NCT03975387
- Sponsor
- Taiho Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-11
- Primary completion
- 2023-09-11
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.